PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients

Polyamine depletion therapy represents a unique cancer immunotherapy approach Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advanc...
Continue Reading →
Quotient